Genetic Variants of SARS-CoV-2—What Do They Mean?

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557

Spike mutation D614G alters SARS-CoV-2 fitness

Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Munnink, B. B. O., Sikkema, R. S., Nieuwenhuijse, D. F., Molenaar, R. J., Münger, E., Molenkamp, R., van der Spek, A. N., Tolsma, P., Rietveld, A., Brouwer, M., et al. (2020) · Science · doi:10.1126/science.abe5901 · Cited by 1,116

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityPreprint

Volz, E., Hill, V., McCrone, J., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166082 · Cited by 313

We shouldn’t worry when a virus mutates during disease outbreaks

Grubaugh, N. D., Petrone, M. E., & Holmes, E. C. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0690-4 · Cited by 168

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness

Tulimilli, S. V., Dallavalasa, S., Basavaraju, C. G., Rao, V. K., Chikkahonnaiah, P., Madhunapantula, S. V., & Veeranna, R. P. (2022) · Vaccines · doi:10.3390/vaccines10101751 · Cited by 39

SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface

Sharun, K., Tiwari, R., Saied, A. A., & Dhama, K. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.053 · Cited by 37

Point‐of‐Care Platform for Rapid Multiplexed Detection of SARS‐CoV‐2 Variants and Respiratory Pathogens

Trick, A. Y., Chen, F., Chen, L., Lee, P., Hasnain, A. C., Mostafa, H. H., Carroll, K. C., & Wang, T. (2022) · Advanced Materials Technologies · doi:10.1002/admt.202101013 · Cited by 37

Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate

Zhang, F., He, P., Rodrigues, A. L., Jeske, W. P., Tandon, R., Bates, J. T., Bierdeman, M. A., Fareed, J., Dordick, J. S., & Linhardt, R. J. (2022) · Pharmaceuticals · doi:10.3390/ph15020258 · Cited by 37

Molecularly imprinted composite-based biosensor for the determination of SARS-CoV-2 nucleocapsid protein

Drobysh, M., Ratautaitė, V., Brazys, E., Ramanavičienė, A., & Ramanavičius, A. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116043 · Cited by 36

How Aotearoa New Zealand rapidly revised its Covid‐19 response strategy: lessons for the next pandemic plan

Kvalsvig, A., & Baker, M. G. (2021) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2021.1891943 · Cited by 36

SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence

Vargas‐Herrera, N., Araujo-Castillo, R. V., Mestanza, O., Galarza, M., Rojas, N., & Solari, L. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100112 · Cited by 36

Integrated bioinformatics–cheminformatics approach toward locating pseudo‐potential antiviral marine alkaloids against SARS‐CoV‐2‐Mpro

Swain, S. S., Singh, S. R., Sahoo, A., Panda, P. K., Hussain, T., & Pati, S. (2022) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26341 · Cited by 36

SARS-CoV-2 Tests: Bridging the Gap between Laboratory Sensors and Clinical Applications

Toropov, N. A., Osborne, E. L., Joshi, L. T., Davidson, J., Morgan, C., Page, J. W., Pepperell, J., & Vollmer, F. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00612 · Cited by 35

Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy

Gupta, Y. A., Maciorowski, D., Zak, S. E., Kulkarni, C. V., Herbert, A. S., Durvasula, R. V., Fareed, J., Dye, J. M., & Kempaiah, P. M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.148 · Cited by 35

Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria

Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Zayas, J., Bhimalli, P. P., Ash, M. K., et al. (2021) · doi:10.1101/2021.04.09.21255206 · Cited by 34

CESSAT: A chemical additive-enhanced single-step accurate CRISPR/Cas13 testing system for field-deployable ultrasensitive detection and genotyping of SARS-CoV-2 variants of concern

Wang, Y., Chen, H., Gao, H., Wei, H., Wang, Y., Mu, K., Liu, L., Dai, E., Rong, Z., & Wang, S. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115238 · Cited by 34

Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro

Pucci, F., & Rooman, M. J. (2021) · Viruses · doi:10.3390/v13050935 · Cited by 35

Vaccination with S pan , an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice

Zhao, Y., Ni, W., Liang, S., Dong, L., Xiang, M., Cai, Z., Niu, D., Zhang, Q., Wang, D., Zheng, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo3332 · Cited by 34

Vaccine efficacy probable against COVID-19 variants

Luchsinger, L. L., & Hillyer, C. D. (2021) · Science · doi:10.1126/science.abg9461 · Cited by 33

Mink SARS-CoV-2 infection in Poland – short communication

Domańska-Blicharz, K., Orłowska, A., Smreczak, M., Niemczuk, K., Iwan, E., Bomba, A., Lisowska, A., Opolska, J., Trębas, P., Potyrało, P., et al. (2021) · Journal of Veterinary Research · doi:10.2478/jvetres-2021-0017 · Cited by 33

Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease‐19 pandemic

Chadha, J., Khullar, L., & Mittal, N. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15687 · Cited by 33

The Immune Response to SARS-CoV-2 and Variants of Concern

Torbati, E., Krause, K. L., & Ussher, J. E. (2021) · Viruses · doi:10.3390/v13101911 · Cited by 36

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France

Hoang, V. T., Colson, P., Levasseur, A., Delerce, J., Lagier, J., Parola, P., Million, M., Fournier, P., Raoult, D., & Gautret, P. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105092 · Cited by 32

Photonics enabled intelligence system to identify SARS-CoV 2 mutations

Taha, B. A., Al-Jubouri, Q., Mashhadany, Y. I. M. A., Zan, M. S. D., Bakar, A. A. A., Fadhel, M. M., & Arsad, N. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11930-1 · Cited by 32

Epigenomics in COVID-19; the Link Between DNA Methylation, Histone Modifications and SARS-CoV-2 Infection

Shirvaliloo, M. (2021) · Epigenomics · doi:10.2217/epi-2021-0057 · Cited by 32

Learning from the past: Taiwan’s responses to COVID-19 versus SARS

Yen, M., Yen, Y., Chen, S., Lee, T.-I., Huang, K.-H., Chan, T., Tung, T.-H., Hsu, L., Chiu, T., Hsueh, P., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.06.002 · Cited by 31

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression

Pratama, N. R., Wafa, I. A., Budi, D. S., Sutanto, H., Asmarawati, T. P., Barlian Effendi, G., & Wungu, C. D. K. (2022) · Vaccines · doi:10.3390/vaccines10122180 · Cited by 30

Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses

Ayoub, H. H., Chemaitelly, H. S., Makhoul, M., Kanaani, Z. A., Al‐Kuwari, E., Butt, A. A., Coyle, P. V., Jeremijenko, A. M., Kaleeckal, A. H., Latif, A. N., et al. (2021) · BMJ Innovations · doi:10.1136/bmjinnov-2021-000677 · Cited by 30

Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective

Miao, M., Clercq, E. D., & Li, G. (2021) · Biomedicines · doi:10.3390/biomedicines9040412 · Cited by 32

COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms

Campos-Ferreira, D. S., Visani, V., Córdula, C., Nascimento, G. A., Montenegro, L. M. L., Schindler, H. C., & Cavalcanti, I. M. F. (2021) · Biochemical Engineering Journal · doi:10.1016/j.bej.2021.108200 · Cited by 30

Coronavirus Disease 2019: Clinics, Treatment, and Prevention

Burkert, F. R., Lanser, L., Bellmann‐Weiler, R., & Weiß, G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.761887 · Cited by 30

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study

Singer, S. R., Angulo, F. J., Swerdlow, D. L., McLaughlin, J. M., Hazan, I., Ginish, N., Anis, E., Mendelson, E., Mor, O., Zuckerman, N. S., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101190 · Cited by 31

Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG

Winklmeier, S., Eisenhut, K., Taskin, D., Rübsamen, H., Gerhards, R., Schneider, C., Wratil, P. R., Stern, M., Eichhorn, P., Keppler, O. T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103659 · Cited by 31

Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China

Makhoul, M., Chemaitelly, H. S., Ayoub, H. H., Seedat, S., & Abu-Raddad, L. J. (2021) · Vaccines · doi:10.3390/vaccines9030223 · Cited by 29

The variants question: What is the problem?

Zella, D., Giovanetti, M., Benedetti, F., Unali, F., Spoto, S., Guarino, M. P. L., Angeletti, S., & Ciccozzi, M. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27196 · Cited by 29

20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment

Margolin, L., Luchins, J., Margolin, D., Margolin, M., & Lefkowitz, S. (2021) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x211026193 · Cited by 32

Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence

Riccio, A., Santopolo, S., Rossi, A., Piacentini, S., Rossignol, J., & Santoro, M. G. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04246-w · Cited by 29

The Mutational Landscape of SARS-CoV-2

Saldivar‐Espinoza, B., Garcia‐Segura, P., Novau-Ferré, N., Macip, G., Martínez, R., Puigbò, P., Cereto‐Massagué, A., Pujadas, G., & Garcı́a-Vallvé, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109072 · Cited by 30

Using machine learning for predicting intensive care unit resource use during the COVID-19 pandemic in Denmark

Lorenzen, S. S., Nielsen, M., Jimenez‐Solem, E., Petersen, T. S., Perner, A., Thorsen‐Meyer, H., Igel, C., & Sillesen, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-98617-1 · Cited by 29

Development and validation of a clinical and genetic model for predicting risk of severe COVID-19

Dite, G. S., Murphy, N. M., & Allman, R. (2021) · Epidemiology and Infection · doi:10.1017/s095026882100145x · Cited by 27

Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets

Vaidya, N. K., Bloomquist, A., & Perelson, A. S. (2021) · Viruses · doi:10.3390/v13081635 · Cited by 27

People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden

Cillo, A. R., Somasundaram, A., Shan, F., Cardello, C., Workman, C. J., Kitsios, G. D., Ruffin, A. T., Kunning, S. R., Lampenfeld, C., Onkar, S., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100476 · Cited by 28

Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review

Kozłowski, P., Leszczyńska, A., & Ciepiela, O. (2024) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2024.100068 · Cited by 27

Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic

Rahman, S., Hossain, M. J., Nahar, Z., Shahriar, M., Bhuiyan, M. A., & Islam, M. R. (2022) · Environmental Health Insights · doi:10.1177/11786302221129396 · Cited by 27

Data-driven analysis of amino acid change dynamics timely reveals SARS-CoV-2 variant emergence

Bernasconi, A., Mari, L., Casagrandi, R., & Ceri, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00496-z · Cited by 26

Electrochemical biosensing based comparative study of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein

Drobysh, M., Liustrovaitė, V., Kanetski, Y., Brasiūnas, B., Žvirblienė, A., Rimkutė, A., Gudas, D., Kučinskaitė-Kodzė, I., Simanavičius, M., Ramanavičius, S., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168154 · Cited by 26

Time scale performance of rapid antigen testing for SARS‐CoV‐2: Evaluation of 10 rapid antigen assays

Abusrewil, Z., Alhudiri, I. M., Kaal, H. H., Meshri, S. E. E., Ebrahim, F. O., Dalyoum, T., Efrefer, A. A., Ibrahim, K., Elfghi, M. B., Abusrewil, S., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27186 · Cited by 25

Rapid test to assess the escape of SARS-CoV-2 variants of concern

Heggestad, J. T., Britton, R. J., Kinnamon, D., Wall, S. A., Joh, D. Y., Hucknall, A., Olson, L. B., Anderson, J. G., Mazur, A., Wolfe, C. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abl7682 · Cited by 25

Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S): Evidence of Measurement Invariance Across Five Countries

Chen, I.-H., Wu, P.-L., Yen, C.-F., Ullah, I., Shoib, S., Zahid, S. U., Bashir, A., Iqbal, N., Addo, F.-M., Adjaottor, E. S., et al. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s351794 · Cited by 25

SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond

Vindeirinho, J. M., Pinho, E., Azevedo, N. F., & Almeida, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.799678 · Cited by 25

Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules

Lamb, K. D., Luka, M. M., Saathoff, M., Orton, R. J., Phan, M. V. T., Cotten, M. L., Yuan, K., & Robertson, D. L. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011795 · Cited by 26

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review

Brosseau, L. M., Escandón-Vargas, K., Ulrich, A. K., Rasmussen, A. L., Roy, C. J., Bix, G. J., Popescu, S. V., Moore, K. A., & Osterholm, M. T. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab903 · Cited by 27

SARS-CoV-2 variants: A double-edged sword?

Jogalekar, M. P., Veerabathini, A., & Gangadaran, P. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211014146 · Cited by 24

Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis

Díaz‐García, H., Guzmán-Ortiz, A. L., Ángeles-Floriano, T., Parra‐Ortega, I., López-Martı́nez, B., Martínez‐Saucedo, M., Aquino‐Jarquín, G., Sánchez‐Urbina, R., Quezada, H., & Granados-Riveron, J. T. (2021) · Genes · doi:10.3390/genes12040531 · Cited by 24

Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19

Lu, R., Ko, S.-H., Wy, C., Chang, Y., Lin, H.-T., & Wu, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212412 · Cited by 25

An overview of the ongoing challenges in SARS-CoV-2 global control

Shehata, A. A., Parvin, R., Nagy, A., Wang, Y., Azhar, T. M., Attia, Y. A., Azhar, E. I., Paul, A. K., & Rahmatullah, M. (2021) · German Journal of Microbiology · doi:10.51585/gjm.2021.2.0006 · Cited by 24

Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach

Carcereny, A., García-Pedemonte, D., Martínez-Velázquez, A., Quer, J., García‐Cehic, D., Gregori, J., Antón, A., Andrés, C., Pumarola, T., Chacón-Villanueva, C., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112720 · Cited by 24

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

Kantarcıoğlu, B., Iqbal, O., Lewis, J., Carter, C. A., Singh, M., Lievano, F. A., Ligocki, M. A., Jeske, W. P., Adıgüzel, C., Gerotziafas, G., et al. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211056648 · Cited by 25

Clinical and Pulmonary CT Characteristics of Patients Infected With the SARS-CoV-2 Omicron Variant Compared With Those of Patients Infected With the Alpha Viral Strain

Yang, N., Wang, C., Huang, J., Dong, J., Ye, J., Fu, Y., Huang, J., Xu, D., Cao, G., & Qian, G. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.931480 · Cited by 24

Broad Antiviral Effects of Echinacea purpurea against SARS-CoV-2 Variants of Concern and Potential Mechanism of Action

Vimalanathan, S., Shehata, M., Kannan, S., Delbue, S., Dolci, M., Pariani, E., D’Alessandro, S., & Pleschka, S. (2022) · Microorganisms · doi:10.3390/microorganisms10112145 · Cited by 24

Artificial Intelligence Applied to Chest X-ray for Differential Diagnosis of COVID-19 Pneumonia

Salvatore, C., Interlenghi, M., Monti, C. B., Ippolito, D., Capra, D., Cozzi, A., Schiaffino, S., Polidori, A., Gandola, D. G., Alì, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030530 · Cited by 24

Effect of RBD mutations in spike glycoprotein of SARS-CoV-2 on neutralizing IgG affinityPreprint

Hayashi, T., Yaegashi, N., & Konishi, I. (2021) · Research Square · doi:10.1101/2021.01.28.21250577 · Cited by 24

PARP1 inhibition protects mice against Japanese encephalitis virus infection

Desingu, P. A., Mishra, S., Dindi, L., Srinivasan, S., Rajmani, R. S., Ravi, V., Tamta, A. K., Raghu, S., Murugasamy, K., Pandit, A. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113103 · Cited by 23

Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies

Barghash, R. F., Gemmati, D., Awad, A. M., Elbakry, M. M. M., Tisato, V., Awad, K., & Singh, A. V. (2024) · Molecules · doi:10.3390/molecules29235564 · Cited by 24

Evaluation of rapid SARS-CoV-2 antigen tests, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 patients

Kweon, O. J., Lim, Y. K., Kim, H. R., Choi, Y., Kim, M., Choi, S. H., Chung, J.-W., & Lee, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249972 · Cited by 23

An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern

Morris, C. P., Luo, C. H., Amadi, A., Schwartz, M. C., Gallagher, N., Ray, S. C., Pekosz, A. S., & Mostafa, H. H. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab636 · Cited by 25

Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies

Galili, U. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.746883 · Cited by 23

COV2Var, a function annotation database of SARS-CoV-2 genetic variation

Feng, Y., Yi, J., Yang, L., Wang, Y., Wen, J., Zhao, W., Kim, P., & Zhou, X. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad958 · Cited by 26

Challenges and Issues of Anti-SARS-CoV-2 Vaccines

Blumental, S., & Debré, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.664179 · Cited by 22

Tetra-primer ARMS-PCR combined with dual-color fluorescent lateral flow assay for the discrimination of SARS-CoV-2 and its mutations with a handheld wireless reader

Wang, Y., Chen, H., Wei, H., Rong, Z., & Wang, S. (2022) · Lab on a Chip · doi:10.1039/d1lc01167g · Cited by 22

CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity

Long, Y., Sun, J., Song, T., Liu, T., Tang, F., Zhang, X., Ding, L., Miao, Y., Zhu, W., Pan, X., et al. (2022) · Cell Discovery · doi:10.1038/s41421-021-00370-2 · Cited by 22

Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron

Chakraborty, C., Bhattacharya, M., Sharma, A. R., Dhama, K., & Lee, S. (2022) · GeroScience · doi:10.1007/s11357-022-00619-y · Cited by 22

From Bulk to Nanoparticles: An Overview of Antiviral Materials, Its Mechanisms, and Applications

Rodrigues, I. C. P., Campo, K. N., Arns, C. W., Gabriel, L. P., Webster, T. J., & Lopes, É. S. N. (2021) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202100044 · Cited by 22

Modeling the Impacts of Physical Distancing and Other Exposure Determinants on Aerosol Transmission

Wagner, J., Sparks, T. L., Miller, S., Chen, W., Macher, J. M., & Waldman, J. M. (2021) · Journal of Occupational and Environmental Hygiene · doi:10.1080/15459624.2021.1963445 · Cited by 21

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection

Chakraborty, C., Bhattacharya, M., Sharma, A. R., Lee, S., & Agoramoorthy, G. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102428 · Cited by 21

SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection

Lodhi, N., Singh, R., Rajput, S., & Saquib, Q. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168660 · Cited by 21

Will the next spillover pandemic be deadlier than the COVID-19?: A wake-up call

Choudhary, O. P., Priyanka, Ali, R. K., Maulud, S. Q., Dhawan, M. K., & Mohammed, T. A. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.106208 · Cited by 21

Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants

Simões, R. S. D. Q., & Rodrı́guez-Làzaro, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042392 · Cited by 22

SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response

Xiao, C., Mao, L., Wang, Z., Gao, L., Zhu, G., Su, J., Chen, X., Yuan, J., Hu, Y., Yin, Z., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103934 · Cited by 21

Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis

Fischer, T., Baz, Y. E., Graf, N., Wildermuth, S., Leschka, S., Kleger, G., Pietsch, U., Frischknecht, M., Scanferla, G., Strahm, C., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051201 · Cited by 21

Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast

Inchingolo, A. D., Malcangi, G., Ceci, S., Patano, A., Corriero, A., Vimercati, L., Azzollini, D., Marinelli, G., Coloccia, G., Piras, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158485 · Cited by 22

Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out

Mumtaz, G. R., El‐Jardali, F., Jabbour, M., Harb, A., Abu-Raddad, L. J., & Makhoul, M. (2021) · Vaccines · doi:10.3390/vaccines9070697 · Cited by 23

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

Rais, Y., Fu, Z., & Drabovich, A. P. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09325-x · Cited by 23

Point-of-care COVID-19 testing in the emergency department: current status and future prospects

May, L. S., Tran, N. K., & Ledeboer, N. A. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.2005582 · Cited by 21

New insights on circular RNAs and their potential applications as biomarkers, therapeutic agents, and preventive vaccines in viral infections: with a glance at SARS-CoV-2

Rahmani-Kukia, N., & Abbasi, A. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.012 · Cited by 22

Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative

Kyei-Barffour, I., Akwetey, S. A., Aninagyei, E., Ghartey‐Kwansah, G., & Acheampong, D. O. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112282 · Cited by 21

Molecular Level Dissection of Critical Spike Mutations in SARS‐CoV‐2 Variants of Concern (VOCs): A Simplified Review

Joshi, N., Tyagi, A., & Nigam, S. (2021) · ChemistrySelect · doi:10.1002/slct.202102074 · Cited by 21

Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach

Palanisamy, K., Rubavathy, S. M. E., Prakash, M., Thilagavathi, R., Hosseini‐Zare, M. S., & Selvam, C. (2022) · RSC Advances · doi:10.1039/d1ra08604a · Cited by 20

Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to investigate COVID-19 host genetics

Lee, H., Chubachi, S., Namkoong, H., Tanaka, H., Otake, S., Nakagawara, K., Morita, A., Fukushima, T., Watase, M., Kusumoto, T., et al. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00217-z · Cited by 20

Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors

Yazdani, B., Sirous, H., Brogi, S., & Calderone, V. (2023) · Viruses · doi:10.3390/v15122291 · Cited by 20

The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study

Bartsch, S. M., O’Shea, K. J., John, D. C., Strych, U., Bottazzi, M. E., Martinez, M. F., Ciciriello, A., Chin, K. L., Weatherwax, C., Velmurugan, K., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102369 · Cited by 20

Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level

Sallam, M., & Mahafzah, A. M. (2021) · Pathogens · doi:10.3390/pathogens10030302 · Cited by 23

Variantes de SARS-CoV-2, una historia todavía inacabada

Pérez-Abeledo, M., & Moreno, J. C. S. (2021) · Vacunas · doi:10.1016/j.vacun.2021.06.003 · Cited by 20

COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development

Giau, V. V., Bagyinszky, E., & An, S. S. A. (2022) · Microorganisms · doi:10.3390/microorganisms10030598 · Cited by 21

Narrative Review of the COVID-19 Pandemic’s First Two Years in Italy

Beccia, F., Pilla, A. D., Causio, F. A., Federico, B., Specchia, M. L., Favaretti, C., Boccia, S., & Damiani, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315443 · Cited by 20

The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis

Li, X., Xiong, M., Deng, Q., Guo, X., & Li, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24534 · Cited by 19

Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron

Yu, C. Y., Wong, S. Y., Liew, N. W. C., Joseph, N. M. S., Zakaria, Z., Isa, N. M., Soe, H. J., Kairon, R., Nordin, S. A., & Chee, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1001022 · Cited by 19

COVID-19 mutations: An overview

Sarkar, M. S., & Madabhavi, I. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i3.89761 · Cited by 22

SARS-CoV-2 spillover transmission due to recombination event

Shahhosseini, N., Wong, G., Kobinger, G., & Chinikar, S. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101045 · Cited by 20

Association of SARS-CoV-2 Clades with Clinical, Inflammatory and Virologic Outcomes: An Observational Study

Young, B. E., Wei, W. E., Fong, S., Mak, T. M., Anderson, D. E., Chan, Y., Pung, R., Heng, C. S., Ang, L. W., Zheng, A. K. E., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2021.103319 · Cited by 18

Rapid Detection of Intact SARS-CoV-2 Using Designer DNA Nets and a Pocket-Size Smartphone-Linked Fluorimeter

Lee, H., Wang, W., Chauhan, N., Xiong, Y., Magazine, N., Valdescruz, O., Kim, D. Y., Qiu, T., Huang, W., Wang, X., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115228 · Cited by 18

How prepared is Mozambique to treat COVID-19 patients? A new approach for estimating oxygen service availability, oxygen treatment capacity, and population access to oxygen-ready treatment facilities

Denhard, L., Kaviany, P., Chicumbe, S., Muianga, C., Laisse, G., Aune, K. T., & Sheffel, A. (2021) · International Journal for Equity in Health · doi:10.1186/s12939-021-01403-8 · Cited by 18

Comparative phylogenetic analysis of SARS-CoV-2 spike protein—possibility effect on virus spillover

Ghorbani, A., Samarfard, S., Eskandarzade, N., Afsharifar, A., Eskandari, M. H., Niazi‎, A., Izadpanah, K., & Karbanowicz, T. P. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab144 · Cited by 18

Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?

Abas, A. H., Marfuah, S., Idroes, R., Kusumawaty, D., Fatimawali, F., Park, M. N., Siyadatpanah, A., Alhumaydhi, F. A., Mahmud, S., Tallei, T. E., et al. (2022) · Molecules · doi:10.3390/molecules27072221 · Cited by 18

Genetic variants of SARS-CoV-2 and its clinical implications

Lara, A. E., Díaz, G. E. F., Benítez, S. N. G., & Soca, P. E. M. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)

SARS-COV-2: INSIGHT INTO THE EMERGING GENETIC VARIANTS

Korsun, N., Trifonova, I. T., Dobrinov, V., Grigorova, I., Angelova, S. G., & Alexiev, I. (2022) · PROBLEMS of Infectious and Parasitic Diseases · doi:10.58395/pipd.v49i3.73

Are new genome variants detected in SARS-CoV-2 expected considering population dynamics in viruses?

Ergören, M. Ç., Tulay, P., & Dündar, M. (2021) · The EuroBiotech Journal · doi:10.2478/ebtj-2021-0001 · Cited by 2

Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance

Dholariya, S. J., Parchwani, D. N., Singh, R., Sonagra, A. D., Motiani, A., & Patel, D. D. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-00991-0 · Cited by 13

COVID Mutation and Effect on Vaccine

Tian, Z. (2022) · Applied economics and policy studies · doi:10.1007/978-981-19-0564-3_5